S&P 500   4,967.23
DOW   37,986.40
QQQ   414.65
How major US stock indexes fared Friday, 4/19/2024
Stock market today: Tumbling tech stocks drag Wall Street to the finish line of another losing week
American Express profits jump 34%, helped by jump in new customers, higher spending
American Express, Fifth Third rise; Netflix, PPG Industries fall, Friday, 4/19/2024
Intuitive Surgical Stock Can Trend Much Higher This Year 
3 Magnificent Seven Stocks Outperforming the Rest
Bargain Hunting: 3 Stocks With RSIs That Scream Oversold
S&P 500   4,967.23
DOW   37,986.40
QQQ   414.65
How major US stock indexes fared Friday, 4/19/2024
Stock market today: Tumbling tech stocks drag Wall Street to the finish line of another losing week
American Express profits jump 34%, helped by jump in new customers, higher spending
American Express, Fifth Third rise; Netflix, PPG Industries fall, Friday, 4/19/2024
Intuitive Surgical Stock Can Trend Much Higher This Year 
3 Magnificent Seven Stocks Outperforming the Rest
Bargain Hunting: 3 Stocks With RSIs That Scream Oversold
S&P 500   4,967.23
DOW   37,986.40
QQQ   414.65
How major US stock indexes fared Friday, 4/19/2024
Stock market today: Tumbling tech stocks drag Wall Street to the finish line of another losing week
American Express profits jump 34%, helped by jump in new customers, higher spending
American Express, Fifth Third rise; Netflix, PPG Industries fall, Friday, 4/19/2024
Intuitive Surgical Stock Can Trend Much Higher This Year 
3 Magnificent Seven Stocks Outperforming the Rest
Bargain Hunting: 3 Stocks With RSIs That Scream Oversold
S&P 500   4,967.23
DOW   37,986.40
QQQ   414.65
How major US stock indexes fared Friday, 4/19/2024
Stock market today: Tumbling tech stocks drag Wall Street to the finish line of another losing week
American Express profits jump 34%, helped by jump in new customers, higher spending
American Express, Fifth Third rise; Netflix, PPG Industries fall, Friday, 4/19/2024
Intuitive Surgical Stock Can Trend Much Higher This Year 
3 Magnificent Seven Stocks Outperforming the Rest
Bargain Hunting: 3 Stocks With RSIs That Scream Oversold
NASDAQ:IKAN

(IKAN) (IKAN) Stock Price, News & Analysis

Notice: This company has been marked as potentially delisted and may not be actively trading.
Today's Range
N/A
50-Day Range
N/A
52-Week Range
N/A
Volume
N/A
Average Volume
41,891 shs
Market Capitalization
N/A
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
IKAN stock logo

About (IKAN) Stock (NASDAQ:IKAN)

Ikanos Communications, Inc. is a provider of advanced semiconductor products and software for delivering broadband solutions to the connected home. The Company is engaged in the design, development, marketing and sale of semiconductors and integrated firmware. It offers broadband multi-mode and digital subscriber line (DSL) processors, other semiconductor offerings power carrier infrastructure (Access) and customer premises equipment (Gateway) for network equipment manufacturers (NEMs) supplying telecommunications service providers. Its products are at the core of DSL access multiplexers (DSLAMs), optical network terminals (ONTs), concentrators, modems, voice over Internet Protocol (VoIP) terminal adapters, integrated access devices (IADs) and residential gateways (RGs). It also offers a line of multi-mode communications processors (CPs) for RGs that can support a variety of wide area network topologies for telecom carriers, wireless carriers and cable multiple system operators.

IKAN Stock News Headlines

Tiny Biotech Stock Wins $75 Billion Patent
A little-known biotech has been quietly working on revolutionary treatments for neurodegenerative diseases. Most people have never heard of them... but those in the know have been taking notice. Jeff Bezos cut them a check for $130 million. Fidelity Biosciences for a further $217 million. They've even had several collaborative partnerships with much larger companies like Biogen, Sanofi, and Takeda.
Tiny Biotech Stock Wins $75 Billion Patent
A little-known biotech has been quietly working on revolutionary treatments for neurodegenerative diseases. Most people have never heard of them... but those in the know have been taking notice. Jeff Bezos cut them a check for $130 million. Fidelity Biosciences for a further $217 million. They've even had several collaborative partnerships with much larger companies like Biogen, Sanofi, and Takeda.
FG’s N90 billion Hajj politics
Strategic economic initiatives
Savoury, spicy treat off the grill
Earning a living with drinks stall
See More Headlines
Receive IKAN Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for (IKAN) and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Last Earnings
1/22/2015
Today
4/19/2024

Industry, Sector and Symbol

Sector
N/A
Industry
N/A
Sub-Industry
N/A
Current Symbol
NASDAQ:IKAN
Fax
N/A
Employees
N/A
Year Founded
N/A

Profitability

Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
N/A

Miscellaneous

Free Float
N/A
Optionable
Not Optionable
Beta
N/A
10 "Recession Proof" Stocks That Will Thrive in Any Market Cover

Which stocks are likely to thrive in today's challenging market? Click the link below and we'll send you MarketBeat's list of ten stocks that will drive in any economic environment.

Get This Free Report

IKAN Stock Analysis - Frequently Asked Questions

How were (IKAN)'s earnings last quarter?

(IKAN) (NASDAQ:IKAN) released its quarterly earnings results on Thursday, January, 22nd. The communications equipment provider reported ($0.07) EPS for the quarter, missing the consensus estimate of ($0.05) by $0.02. The communications equipment provider earned $11.50 million during the quarter.

What other stocks do shareholders of (IKAN) own?

Based on aggregate information from My MarketBeat watchlists, some companies that other (IKAN) investors own include Nokia Oyj (NOK), CDTi Advanced Materials (CDTI), Towerstream (TWER), ALU (ALU), Intel (INTC), Micron Technology (MU), Orexigen Therapeutics (OREX), Yandex (YNDX) and Achillion Pharmaceuticals (ACHN).

This page (NASDAQ:IKAN) was last updated on 4/19/2024 by MarketBeat.com Staff

From Our Partners